Both in Pharmaceuticals
Summit Therapeutics vs Jazz Pharmaceuticals
Over the past year SMMT returned −7.5% and JAZZ returned +70.3%; their daily moves had a correlation of 0.15.
SMMT −7.5% JAZZ +70.3%Growth of $1, one year, split-adjusted
| Metric | SMMT | JAZZ |
|---|---|---|
| Price | $16.17 | $234.66 |
| Market cap | $12.90B | $15.23B |
| Today | +2.34% | +2.14% |
| 1 month | −6.6% | +1.4% |
| 6 months | −9.4% | +2.7% |
| Year to date | −7.5% | +38.0% |
| 1 year | −11.3% | +69.6% |
| Revenue growth (YoY) | — | +10.4% |
| Gross margin | — | 91.1% |
| Net margin | — | −38.9% |
| P/E (TTM) | — | 74.0× |
| Price / sales | — | 3.2× |
| Net cash | $690.7M | -$2.71B |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 31.2% |
| Short % of float | 29.5% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).